IBRX

NASD ImmunityBio Inc
Oct 6, 2026 · 8:08 AM ET LAST TRADE Market Closed

$10.35 ↓ -0.03 (-0.29%) Trading Down from the previous close of $10.38

YTD change
+422.73%
vs 20-day SMA
+19.29%
vs 200-day SMA
+42.83%

Price ranges

Previous day
$10.13 $10.81
open $10.67 close $10.38
-$0.29 (-2.72%)
Today
$0.00 $0.00
$10.35
Past week
$8.52 $10.81
from $8.52 now $10.35
+$1.83 (+21.48%)
Past month
$7.64 $10.81
from $8.08 now $10.35
+$2.27 (+28.09%)
This year
$1.98 $12.43
from $1.98 now $10.35
+$8.37 (+422.73%)

Price & Performance

+3.30 (+46.61%) / 6M

$6.43$7.84$9.26$10.67Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 74.7% away from all-time highs of $40.83
  • IBRX is up 423% since the beginning of the year
  • IBRX is up 309% over the past 12 months
  • IBRX is up 28% over the past 1 month
  • 31% of all IBRX investors are betting against IBRX

IBRX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +310.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.22
Earnings momentum -214.3% Quarterly EPS growth
Quarterly change -214.3%

Valuation

P/E ratio N/A
Enterprise value $11.8B
Beta -0.34

Balance sheet & scale

IncomeN/A
Revenue$165.8M
Cash$357.4M
Debt$1.2M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $11.0B

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $402.98 -0.01%
MRNA Moderna, Inc. $203.21 +6.95%
RVMD Revolution Medicines, Inc. $207.68 +0.50%
ROIV Roivant Sciences Ltd. $35.78 +0.17%
BNTX BioNTech SE Sponsored ADR $97.64 +0.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.